NL-OMON29906尚未招募不适用
A Randomized, Open-Label, Single-Center, Crossover Study of the Potential Effects of Paroxetine on the Pharmacokinetics of a Single Dose of Paliperidone Extended-Release in Healthy Men - DDI-study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects, aged 18-55 years, inclusive
- •Extensive metabolizer of CYP2D6. Subjects whose CYP2D6 genotype is unknown should have been phenotyped before the start of the study.
排除标准
- •Relevant history or presence of any cardiovascular (including myocardial infarct or cardiac arrhythmia), respiratory, neurologic (including seizures), psychiatric, renal, hepatic, gastrointestinal (including surgeries, severe gastrointestinal narrowing, and malabsorption problems), endocrine, hematologic, or immunologic disease
- •Known history of drug-induced dystonia
研究者
相似试验
已完成
不适用
An open-label, randomized, single center, crossover study in healthy participants to assess lipoprotein lipase activity and levels, and triglyceride levels after heparin exposure, in both fasted and postprandial statecardiovascular diseaseNL-OMON50416ovo Nordisk12
已完成
不适用
Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult VolunteersDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0001861Dong-A ST56
进行中（未招募）
不适用
A single-center, open-label, crossover, randomized study to investigate the impact of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestogene (material no. 80876395) in a 21-day regimen as compared to a monophasic contraceptive containing ethinyestradiol and levonogestrel (0.33 mg/0.15 mg) in a 21-day regimen on hemostatic parameters in 30 women aged 18-35 years over 3 treatment cycles in each period - FC-Patch Metabolism Studyhealthy volunteersMedDRA version: 9.1Level: LLTClassification code 10060346Term: Transdermal contraceptionMedDRA version: 9.1Level: LLTClassification code 10030970Term: Oral contraceptionEUCTR2008-007024-26-DEBayer Healthcare AG
已完成
不适用
To determine the Glycaemic Index of Health Food Drinks.CTRI/2022/07/044082Hindustan Unilever Limited20
已完成
不适用
An Open-label, Randomized, Crossover, Single Ascending Dose Pharmacokinetic Study of Continuous Subcutaneous Infusion of Lenalidomide Compared with Revlimid® Oral Capsules in Healthy Adult Male Subjectsmultiple myelomaNL-OMON50544Starton Therapeutics16